GO:0071624 positive regulation of granulocyte chemotaxis: Immune Cell Recruitment Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0071624 describes any process that increases the rate, frequency, or extent of granulocyte chemotaxis, the directed movement of granulocytes (neutrophils, eosinophils, basophils) toward an external chemical stimulus.
• Positive regulation of granulocyte chemotaxis is essential for rapid innate immune responses, but its dysregulation contributes to inflammatory diseases, sepsis, acute respiratory distress syndrome, and cancer progression [3,5,6].
• Key chemokine receptors such as CXCR1 and CXCR2, and their ligands including CXCL5, are central to driving neutrophil recruitment and are actively studied as therapeutic targets [3,5].
• Intracellular pH, cytoskeletal feedback loops, and signaling excitability are critical modulators of granulocyte chemotaxis, revealing layers of regulation beyond simple ligand-receptor interactions [4,8].
• Tumor-associated neutrophils and their chemotactic recruitment can promote lymph node metastasis and suppress CD8+ T cell immunity, linking this GO term directly to cancer biology [3,7].
• CRISPR-based knockout, knock-in, and overexpression models are powerful tools to dissect the causal roles of specific genes in positive regulation of granulocyte chemotaxis.
Description
Granulocytes, including neutrophils, eosinophils, and basophils, are the first responders of the innate immune system. Their ability to migrate directionally along chemical gradients, a process known as granulocyte chemotaxis, is fundamental for host defense. GO:0071624, positive regulation of granulocyte chemotaxis, encompasses all molecular and cellular events that enhance the rate, frequency, or extent of this directed movement [1,5]. Understanding this process is critical because excessive or misdirected granulocyte recruitment underlies a wide range of pathologies, from acute respiratory distress syndrome to cancer metastasis [3,5,7]. Research into this GO term spans chemokine biology, cytoskeletal dynamics, and signal transduction, making it a vibrant area for both basic and translational studies [4,6,8].
positive regulation of granulocyte chemotaxis At A Glance
| GO ID | GO:0071624 |
|---|---|
| GO term | positive regulation of granulocyte chemotaxis |
| Ontology | biological_process |
| Synonym | None |
| Major function | Enhancement of directed migration of granulocytes (neutrophils, eosinophils, basophils) in response to external stimuli |
| Related processes | Chemotaxis, leukocyte migration, inflammatory response, innate immune response |
| Key molecules | Chemokines (e.g., CXCL5, IL-8), chemokine receptors (CXCR1, CXCR2), adhesion molecules, cytoskeletal regulators |
| Disease relevance | Sepsis, acute respiratory distress syndrome, cancer metastasis, chronic inflammatory diseases |
What Is GO:0071624?
According to the Gene Ontology, GO:0071624 is defined as any process that increases the rate, frequency or extent of granulocyte chemotaxis. Granulocyte chemotaxis itself is the movement of a granulocyte in response to an external stimulus. In simpler terms, this GO term covers all the ways cells can boost the directed migration of granulocytes toward chemical cues, such as chemokines, complement fragments, or bacterial products.
Why Is positive regulation of granulocyte chemotaxis Important in Cell Biology?
Positive regulation of granulocyte chemotaxis is a cornerstone of innate immunity, enabling rapid recruitment of neutrophils and other granulocytes to sites of infection or injury. However, when this regulation goes awry, it can drive tissue damage in inflammatory diseases such as acute respiratory distress syndrome and sepsis, or promote tumor progression by fostering an immunosuppressive microenvironment [3,5,6,7]. Therefore, understanding the molecular mechanisms that positively regulate granulocyte chemotaxis is essential for developing targeted therapies that can either boost host defense or dampen pathological inflammation.
• Enables rapid innate immune response by directing granulocytes to infection sites.
• Dysregulation contributes to acute respiratory distress syndrome and sepsis [5,6].
• Promotes cancer progression by recruiting tumor-associated neutrophils that suppress CD8+ T cell immunity [3,7].
• Involves complex signaling networks including chemokine receptors, cytoskeletal feedback, and intracellular pH regulation [4,8].
• Serves as a target for anti-inflammatory and anti-cancer therapies [3,5].
• Provides a model system to study cell polarity and directed migration.
• Links to primary atopic disorders and other immune dysregulation conditions.
• Can be modulated by CSF1R signaling inhibitors that reprogram tumor-associated macrophages.
What Happens During positive regulation of granulocyte chemotaxis?
Chemokine Sensing and Receptor Activation
In simple terms: Granulocytes detect chemical signals from afar and get ready to move.
The process begins when chemokines such as CXCL5 or IL-8 bind to G-protein-coupled receptors like CXCR1 and CXCR2 on the granulocyte surface [3,5]. This binding triggers conformational changes that activate intracellular signaling cascades, including G-protein activation and downstream phosphorylation events. In lung cancer, CXCL5 upregulates PD-L1 via PXN/AKT signaling and promotes neutrophil chemotaxis, illustrating how tumor-derived chemokines can hijack this process. The regulation of neutrophil migration in sepsis involves a complex interplay of chemokine receptors and their modulation.
Intracellular Signaling and Amplification
In simple terms: Inside the cell, signals are amplified to make the response stronger.
Upon receptor activation, multiple signaling pathways are engaged, including PI3K/AKT, MAPK, and Rho GTPase cascades [3,4]. These pathways amplify the initial signal and coordinate cytoskeletal rearrangements. Intracellular pH has been shown to regulate human neutrophil chemotaxis, with changes in pH modulating the activity of key enzymes and ion channels. Cytoskeletal feedback loops control signal transduction excitability and cell polarity, ensuring that the cell maintains a persistent direction of migration.
Cytoskeletal Rearrangement and Cell Polarization
In simple terms: The cell changes its shape to move forward.
Positive regulation of chemotaxis requires dynamic reorganization of the actin cytoskeleton, leading to the formation of a leading edge (lamellipodium) and a trailing edge (uropod). This polarization is essential for directed movement. Complementary cytoskeletal feedback loops between actin and microtubules control signal transduction excitability, allowing the cell to respond to shallow gradients with high sensitivity. Adhesion molecules such as integrins also play a role in stabilizing the leading edge and facilitating forward movement.
Migration and Extravasation
In simple terms: The cell physically moves toward the signal and exits blood vessels.
Once polarized, granulocytes migrate along the chemokine gradient toward the source. In vivo, this often involves extravasation from blood vessels into tissues, a process that requires interactions with endothelial cells and breakdown of the basement membrane. In sepsis, neutrophil migration is dysregulated, contributing to organ damage. Tumor-associated neutrophils recruited via chemotaxis can promote lymph node metastasis in lung adenocarcinoma, highlighting the pathological consequences of enhanced migration.
Resolution and Negative Feedback
In simple terms: The response is eventually turned off to prevent damage.
Positive regulation of granulocyte chemotaxis is balanced by negative feedback mechanisms to avoid excessive inflammation. For example, CSF1/CSF1R signaling inhibitor pexidartinib reprograms tumor-associated macrophages and can indirectly affect neutrophil recruitment. Understanding these feedback loops is crucial for developing therapies that modulate granulocyte chemotaxis without compromising host defense.
Key Genes Involved in GO:0071624 positive regulation of granulocyte chemotaxis
The following genes and proteins are key players in the positive regulation of granulocyte chemotaxis, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CXCL5 | Chemokine ligand that promotes neutrophil chemotaxis | Upregulates PD-L1 in lung cancer via PXN/AKT signaling |
| CXCR1 | Receptor for IL-8 and other chemokines | Mediates neutrophil recruitment in acute respiratory distress syndrome |
| CXCR2 | Receptor for CXCL5 and other chemokines | Key driver of neutrophil chemotaxis in inflammation and cancer |
| PXN | Paxillin, focal adhesion adaptor protein | Phosphorylated in CXCL5-induced signaling to promote neutrophil chemotaxis |
| AKT | Serine/threonine kinase | Phosphorylated downstream of CXCL5 to upregulate PD-L1 and enhance chemotaxis |
| CSF1R | Macrophage colony-stimulating factor receptor | Inhibition by pexidartinib reprograms tumor-associated macrophages and may affect neutrophil recruitment |
| ASB8 | E3 ubiquitin ligase | Low ASB8-mediated ubiquitination of ERβ promotes lymph node metastasis via tumor-associated neutrophils |
| ERβ | Estrogen receptor beta | Elevated expression driven by low ASB8 promotes neutrophil-mediated metastasis |
| Rho GTPases | Regulators of actin cytoskeleton | Control cell polarity and migration during chemotaxis |
| PI3K | Phosphoinositide 3-kinase | Generates PIP3 to amplify chemotactic signals |
| Integrins | Cell adhesion molecules | Facilitate extravasation and migration through tissues |
| IL-8 | Chemokine ligand | Activates CXCR1/CXCR2 to induce neutrophil chemotaxis |
| PD-L1 | Immune checkpoint ligand | Upregulated by CXCL5 signaling, contributing to immune evasion |
| NHE1 | Na+/H+ exchanger | Regulates intracellular pH to modulate neutrophil chemotaxis |
| Actin | Cytoskeletal protein | Forms lamellipodia for forward movement |
| Microtubules | Cytoskeletal filaments | Interact with actin to control signal excitability and polarity |
How Is positive regulation of granulocyte chemotaxis Regulated?
Positive regulation of granulocyte chemotaxis is tightly controlled at multiple levels. Chemokine availability and receptor expression are regulated transcriptionally and post-transcriptionally. Intracellular signaling pathways, including PI3K/AKT and MAPK, are modulated by phosphatases and feedback loops [3,4]. Intracellular pH, controlled by ion exchangers such as NHE1, directly affects chemotactic efficiency. In sepsis, the heterogeneity of patients and complex molecular mechanisms lead to dysregulated neutrophil migration. Additionally, tumor-derived factors like CSF1 can reprogram macrophages and indirectly influence neutrophil recruitment.
positive regulation of granulocyte chemotaxis and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CXCR2 | Acute respiratory distress syndrome, sepsis | Knockout mice or human neutrophil-like cell lines with CXCR2 KO |
| CXCL5 | Lung cancer metastasis | Overexpression in tumor cells followed by neutrophil chemotaxis assays |
| ASB8 | Lung adenocarcinoma lymph node metastasis | Knockout in cancer cell lines to assess ERβ ubiquitination and neutrophil recruitment |
| CSF1R | Sarcoma microenvironment | Point mutation or knockout to study macrophage reprogramming and neutrophil infiltration |
| NHE1 | Inflammatory diseases | Knock-in of pH-insensitive mutant to study chemotaxis |
Acute Respiratory Distress Syndrome (ARDS) and Sepsis
In ARDS and sepsis, excessive or dysregulated neutrophil chemotaxis contributes to lung injury and organ failure. CXCR1 and CXCR2 play central roles in neutrophil recruitment to the lungs, and their modulation is a therapeutic strategy. Sepsis patients exhibit heterogeneous neutrophil migration defects, complicating treatment.
Cancer Progression and Metastasis
Tumor-derived chemokines such as CXCL5 recruit neutrophils that suppress CD8+ T cell immunity and promote metastasis. In lung adenocarcinoma, elevated ERβ due to low ASB8-mediated ubiquitination enhances tumor-associated neutrophil recruitment, facilitating lymph node metastasis [3,7]. Targeting chemotaxis pathways may improve cancer immunotherapy.
Primary Atopic Disorders
Primary atopic disorders often involve immune dysregulation, and rapid genomic sequencing can identify mutations affecting granulocyte function and chemotaxis. Understanding these genetic defects helps in diagnosis and personalized management.
From positive regulation of granulocyte chemotaxis-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X promote neutrophil chemotaxis? | Knockout of gene X in HL-60 or primary neutrophils, followed by transwell migration assay |
| Does a specific point mutation in CXCR2 affect ligand binding? | Point mutation knock-in in CXCR2-expressing cell line, then calcium flux and chemotaxis assays |
| Does overexpression of CXCL5 enhance tumor-associated neutrophil recruitment? | Overexpression of CXCL5 in cancer cell lines, co-culture with neutrophils, and in vivo mouse models |
| Does tagging of PXN with GFP affect its localization during chemotaxis? | Tagged knock-in of PXN-GFP in neutrophil-like cells, live-cell imaging |
| Does ASB8 regulate ERβ ubiquitination and neutrophil recruitment? | ASB8 knockout in lung cancer cells, followed by ERβ ubiquitination assays and neutrophil chemotaxis |
| Does CSF1R inhibition affect neutrophil chemotaxis in sarcoma? | CSF1R knockout or point mutation in macrophages, co-culture with neutrophils, and chemotaxis assays |
How to Study the positive regulation of granulocyte chemotaxis Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Transwell migration assay | Number of cells migrating toward chemoattractant | Screening for genes that enhance or inhibit chemotaxis |
| Live-cell imaging | Cytoskeletal dynamics, cell polarity, intracellular pH | Studying real-time behavior of granulocytes during chemotaxis |
| RNA-seq | Transcriptional changes | Identifying genes upregulated during chemotaxis or in disease |
| Phosphoproteomics | Phosphorylation events | Mapping signaling pathways downstream of chemokine receptors |
| CRISPR knockout | Loss-of-function effects | Determining causal role of a gene in chemotaxis |
| CRISPR knock-in | Effects of specific mutations or tags | Studying point mutations or protein localization |
| Overexpression | Gain-of-function effects | Assessing if a gene is sufficient to enhance chemotaxis |
| Bioinformatics analysis | Pathway enrichment, network analysis | Integrating omics data to identify key regulators |
Transwell Migration Assays
Transwell assays are the gold standard for measuring granulocyte chemotaxis in vitro. Cells are placed in the upper chamber and chemoattractants in the lower chamber; migrated cells are quantified. This method is used to study the effects of gene knockouts or overexpression on chemotaxis [3,5].
Live-Cell Imaging and Biosensors
Live-cell imaging with fluorescent biosensors allows real-time visualization of cytoskeletal dynamics, intracellular pH, and signaling events during chemotaxis. For example, pH-sensitive dyes have been used to study the role of intracellular pH in neutrophil chemotaxis. Cytoskeletal feedback loops can be analyzed using FRET-based biosensors.
Genomic and Transcriptomic Profiling
RNA-seq and single-cell sequencing can identify genes differentially expressed during granulocyte chemotaxis or in disease states. Clinical landmark-guided genomic sequencing rapidly identifies primary atopic disorders with immune dysregulation. These approaches help discover novel regulators of chemotaxis.
Proteomics and Phosphoproteomics
Mass spectrometry-based proteomics can quantify phosphorylation events downstream of chemokine receptors. For instance, CXCL5-induced PXN/AKT phosphorylation was identified in lung cancer, linking signaling to neutrophil chemotaxis. Such studies reveal key nodes for therapeutic intervention.
How CRISPR Can Be Used to Study GO:0071624 positive regulation of granulocyte chemotaxis
Knockout
CRISPR knockout is used to delete genes such as CXCR2 or ASB8 to determine their necessity in positive regulation of granulocyte chemotaxis. For example, knocking out CXCR2 in neutrophil-like cells abolishes chemotaxis toward CXCL5 [3,5]. Knockout models are essential for target validation.
Point Mutation
Point mutations can be introduced to study specific amino acid residues critical for receptor function or signaling. For instance, mutating phosphorylation sites in PXN can reveal their role in CXCL5-induced chemotaxis. This approach provides mechanistic insights without confounding effects of complete gene deletion.
Knock-in
Knock-in of tagged proteins (e.g., GFP-PXN) allows visualization of protein localization during chemotaxis. Knock-in of disease-associated mutations can model human conditions. For example, knocking in a pH-insensitive NHE1 mutant can dissect the role of intracellular pH in chemotaxis.
Overexpression
Overexpression of chemokines like CXCL5 or receptors like CXCR2 can enhance chemotaxis and model pathological states. In cancer research, overexpression of CXCL5 in tumor cells promotes neutrophil recruitment and metastasis. Overexpression models are useful for gain-of-function studies.
How EDITGENE Supports positive regulation of granulocyte chemotaxis Research
Researchers studying positive regulation of granulocyte chemotaxis-related genes often need to determine whether a candidate gene is causally involved in enhancing or inhibiting this process. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this research, from gene knockout to precise point mutations and knock-in models.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of granulocyte chemotaxis research.
Frequently Asked Questions About positive regulation of granulocyte chemotaxis
What is GO:0071624 positive regulation of granulocyte chemotaxis?
GO:0071624 is a Gene Ontology biological process term defined as any process that increases the rate, frequency or extent of granulocyte chemotaxis, which is the directed movement of granulocytes in response to an external stimulus.
What genes are involved in positive regulation of granulocyte chemotaxis?
Key genes include chemokines like CXCL5 and IL-8, receptors such as CXCR1 and CXCR2, signaling molecules like PXN and AKT, and regulators such as ASB8 and NHE1 [3,5,7,8].
How does CXCL5 promote neutrophil chemotaxis?
CXCL5 binds to CXCR2 and activates PXN/AKT signaling, which upregulates PD-L1 and enhances neutrophil chemotaxis in lung cancer.
What is the role of intracellular pH in granulocyte chemotaxis?
Intracellular pH regulates human neutrophil chemotaxis by modulating enzyme activity and ion channels, as shown by studies using pH-sensitive dyes.
How is granulocyte chemotaxis dysregulated in sepsis?
In sepsis, neutrophil migration is heterogeneous and complex, involving altered chemokine receptor expression and signaling, which can lead to organ damage.
Can CRISPR be used to study positive regulation of granulocyte chemotaxis?
Yes, CRISPR knockout, knock-in, point mutation, and overexpression models are powerful tools to dissect the causal roles of specific genes in this process.
What diseases are associated with abnormal granulocyte chemotaxis?
Diseases include acute respiratory distress syndrome, sepsis, cancer metastasis, and primary atopic disorders [1,3,5,6,7].
What methods are used to measure granulocyte chemotaxis?
Common methods include transwell migration assays, live-cell imaging, and microfluidic devices, often combined with CRISPR gene editing [3,4,8].
How does ASB8 affect neutrophil recruitment in lung cancer?
Low ASB8-mediated ubiquitination of ERβ leads to elevated ERβ expression, which promotes lymph node metastasis via tumor-associated neutrophils.
What is the role of CSF1R in granulocyte chemotaxis?
CSF1R signaling inhibitor pexidartinib reprograms tumor-associated macrophages and may indirectly affect neutrophil recruitment in the sarcoma microenvironment.
Conclusion
Positive regulation of granulocyte chemotaxis (GO:0071624) is a critical biological process that orchestrates the directed migration of granulocytes to sites of infection and injury. Its dysregulation is implicated in a wide range of diseases, from acute respiratory distress syndrome to cancer metastasis. Understanding the molecular players and mechanisms, such as chemokine receptors, intracellular pH, and cytoskeletal dynamics, offers opportunities for therapeutic intervention. CRISPR-based models and advanced screening technologies are indispensable for dissecting these pathways and identifying new targets.
References
- 1. Niehues T et al.. 2024. Rapid identification of primary atopic disorders (PAD) by a clinical landmark-guided, upfront use of genomic sequencing.. Allergol Select 8:304-323 PMID: 39381601
- 2. Fujiwara T et al.. 2021. CSF1/CSF1R Signaling Inhibitor Pexidartinib (PLX3397) Reprograms Tumor-Associated Macrophages and Stimulates T-cell Infiltration in the Sarcoma Microenvironment.. Mol Cancer Ther 20(8):1388-1399 PMID: 34088832
- 3. Sun D et al.. 2024. CXCL5 impedes CD8(+) T cell immunity by upregulating PD-L1 expression in lung cancer via PXN/AKT signaling phosphorylation and neutrophil chemotaxis.. J Exp Clin Cancer Res 43(1):202 PMID: 39034411
- 4. Kuhn J et al.. 2025. Complementary cytoskeletal feedback loops control signal transduction excitability and cell polarity.. Nat Commun 16(1):7482 PMID: 40796751
- 5. Toya S et al.. 2024. A narrative review of chemokine receptors CXCR1 and CXCR2 and their role in acute respiratory distress syndrome.. Eur Respir Rev 33(173) PMID: 39048127
- 6. Bruserud Ø et al.. 2023. The Regulation of Neutrophil Migration in Patients with Sepsis: The Complexity of the Molecular Mechanisms and Their Modulation in Sepsis and the Heterogeneity of Sepsis Patients.. Cells 12(7) PMID: 37048076
- 7. Wang Y et al.. 2025. Elevated ERβ expression driven by low ASB8-mediated ubiquitination in lung adenocarcinoma promotes lymph node metastasis via tumor-associated neutrophils.. Cell Death Dis 16(1):576 PMID: 40739091
- 8. Simchowitz L et al.. 1986. Regulation of human neutrophil chemotaxis by intracellular pH.. J Biol Chem 261(14):6492-500 PMID: 3009458
